FDA Approved: CICLOPIROX OLAMINE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)

View source ↗

Summary

FDA approved a supplemental application for Ciclopirox Olamine filed by Padagis Israel Pharmaceuticals Ltd, resulting in changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Onychomycosis
• Tinea Corporis
• Tinea Cruris
• Tinea Pedis

Drugs mentioned

• Ciclopirox olamine (Ciclopirox olamine)

Snippet

SUPPL AP for CICLOPIROX OLAMINE (CICLOPIROX OLAMINE)